Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preliminary Examination of the Effects of Sodium Pyruvate Nasal Spray (N115) on Symptoms Associated With COVID19 Long Haulers.

NCT04871815 is registered in ClinicalTrials.gov with Cellular Sciences, inc. as lead sponsor.

NCT NCT04871815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04871815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preliminary Examination of the Effects of Sodium Pyruvate Nasal Spray (N115) on Symptoms Associated With COVID19 Long Haulers.
Lead sponsor
Cellular Sciences, inc.
Phase
Phase 2/3
Overall status
Completed
Start date
April 27, 2021
Completion date
March 7, 2022
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long covid